THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Genzyme director exercises options for 27,000 shares

Email|Print|Single Page| Text size – +
May 7, 2008

NEW YORK—A director of biotech company Genzyme Corp. exercised options for 27,000 shares of common stock, according to a Securities and Exchange Commission filing Tuesday.

In a Form 4 filed with the SEC, Charles L. Cooney reported he exercised options for the shares on Friday for $32.52 and $43.90 apiece, and then sold them all the same day for $70.67 apiece.

Insiders file Form 4s with the SEC to report transactions in their companies' shares. Open market purchases and sales must be reported within two business days of the transaction.

Genzyme is based in Cambridge, Mass.

© Copyright 2008 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

more stories like this

  • Email
  • Email
  • Print
  • Print
  • Single page
  • Single page
  • Reprints
  • Reprints
  • Share
  • Share
  • Comment
  • Comment
 
  • Share on DiggShare on Digg
  • Tag with Del.icio.us Save this article
  • powered by Del.icio.us
Your Name Your e-mail address (for return address purposes) E-mail address of recipients (separate multiple addresses with commas) Name and both e-mail fields are required.
Message (optional)
Disclaimer: Boston.com does not share this information or keep it permanently, as it is for the sole purpose of sending this one time e-mail.